Subramanian Kumar, Sinha Raghu
Department of Biochemistry and Molecular Biology, Penn State College of Medicine, Hershey, PA 17033, USA.
Biomedicines. 2024 Mar 20;12(3):691. doi: 10.3390/biomedicines12030691.
Breast cancer remains a major global health concern, emphasizing the need for reliable biomarkers to enhance early detection and therapeutic interventions. MicroRNAs (miRNAs) are evolutionarily conserved small non-coding RNA (~22 nt in length) molecules, which are aberrantly expressed in cancer and seem to influence tumor behavior and progression. Specific miRNA dysregulation has been associated with breast cancer initiation, proliferation, invasion, and metastasis. Understanding the functional roles of these miRNAs provides valuable insights into the intricate molecular mechanisms underlying breast cancer progression. The diagnostic potential of miRNAs as non-invasive biomarkers for early breast cancer detection is a burgeoning area of research. This review aims to elucidate the functions of differentially regulated miRNAs in breast cancer progression and assess their potential as markers for early detection, stage-specific biomarkers, and therapeutic targets. Furthermore, the ability of specific miRNAs to serve as prognostic indicators and predictors of treatment response highlights their potential clinical utility in guiding personalized therapeutic interventions.
乳腺癌仍然是全球主要的健康问题,这凸显了需要可靠的生物标志物来加强早期检测和治疗干预。微小RNA(miRNA)是进化上保守的小非编码RNA(长度约22个核苷酸)分子,在癌症中异常表达,似乎影响肿瘤行为和进展。特定的miRNA失调与乳腺癌的发生、增殖、侵袭和转移有关。了解这些miRNA的功能作用,为深入了解乳腺癌进展的复杂分子机制提供了有价值的见解。miRNA作为早期乳腺癌检测的非侵入性生物标志物的诊断潜力是一个新兴的研究领域。本综述旨在阐明差异调节的miRNA在乳腺癌进展中的功能,并评估它们作为早期检测标志物、阶段特异性生物标志物和治疗靶点的潜力。此外,特定miRNA作为预后指标和治疗反应预测指标的能力,凸显了它们在指导个性化治疗干预方面的潜在临床应用价值。